Roberta sells DYAX 9.03: Pre-Market Review on Health Care Sector Equities -- Research on Dyax, Repligen, Vanda Pharma, and Ironwood Pharma
LONDON, July 1, 2014 /PRNewswire/ -- The US markets on Thursday, June 30, 2014 mostly ended on a lower note as the Dow Jones Industrial Average finished at 16,826.60, down 0.15% and the NASDAQ Composite ... following equities: Dyax Corp. DYAX, Repligen ... ...
58 people liked this
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home